Selective inhibition of nuclear factor-κB by nuclear factor-κB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma

Cancer Science

Volumn 103, Issue 3, 2012, Pages 455-463

  Tanaka, Takuya ^a   Nakayama, Hideki ^a   Yoshitake, Yoshihiro ^a   Irie, Atsushi ^a   Nagata, Masashi ^a   Kawahara, Kenta ^a   Takamune, Yasuo ^a   Yoshida, Ryoji ^a   Nakagawa, Yoshihiro ^a   Ogi, Hidenao ^a   Shinriki, Satoru ^a   Ota, Kazutoshi ^a   Hiraki, Akimitsu ^a   Ikebe, Tetsuro ^b   Nishimura, Yasuharu ^a   Shinohara, Masanori ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETASTATIC AGENT; BETA1 INTEGRIN; FIBRONECTIN; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 14; NBD PEPTIDE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; VASCULOTROPIN C; NBD PEPTIDE, MOUSE; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; METASTASIS INHIBITION; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION; TUMOR GROWTH; UPREGULATION; ANIMAL; CANCER INVASION; DRUG ANTAGONISM; DRUG SCREENING; EXPERIMENTAL NEOPLASM; METABOLISM; METASTASIS; MOUTH TUMOR; NUDE MOUSE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; NF-KAPPA B; PEPTIDES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84859710559     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02174.x     Document Type: Article

References (39)

1. Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 2007; 26: 645-62.
2. Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol 1992; 158: 961-9.
3. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-72.
4. Harada T, Shinohara M, Nakamura S, Oka M. An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchows Arch 1994; 424: 257-66.
5. Shinohara M, Nakamura S, Harada T, Shimada M, Oka M. Mode of tumor invasion in oral squamous cell carcinoma: improved grading based on immunohistochemical examination of extracellular matrices. Head Neck 1996; 18: 153-9.
6. Shinohara M, Nakamura S, Sasaki M et al. Expression of integrins in squamous cell carcinoma of the oral cavity. Correlations with tumor invasion and metastasis. Am J Clin Pathol 1999; 111: 75-88.
7. Kurahara S, Shinohara M, Ikebe T et al. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 1999; 21: 627-38.
8. Ikebe T, Shinohara M, Takeuchi H et al. Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis 1999; 17: 315-23.
9. Sugiura T, Inoue Y, Matsuki R et al. VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker. Int J Oncol 2009; 34: 673-80.
10. Allen CT, Ricker JL, Chen Z, Van Waes C. Role of activated nuclear factorkappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck. Head Neck 2007; 29: 959-71.
11. Ahn KS, Aggarwal BB. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann N Y Acad Sci 2005; 1056: 218-33.
12. Nakayama H, Ikebe T, Beppu M, Shirasuna K. High expression levels of nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity. Cancer 2001; 92: 3037-44.
13. Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 2000; 12: 85-98.
14. May MJ, D'Acquisto F, Madge LA, Glockner J, Pober JS, Ghosh S. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 2000; 289: 1550-4.
15. May MJ, Marienfeld RB, Ghosh S. Characterization of the Ikappa B-kinase NEMO binding domain. J Biol Chem 2002; 277: 45992-6000.
16. Ikebe T, Takeuchi H, Jimi E, Beppu M, Shinohara M, Shirasuna K. Involvement of proteasomes in migration and matrix metalloproteinase-9 production of oral squamous cell carcinoma. Int J Cancer 1998; 77: 578-85.
17. Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int J Cancer 2004; 111: 679-92.
18. Takamune Y, Ikebe T, Nagano O, Shinohara M. Involvement of NF-kappaBmediated maturation of ADAM-17 in the invasion of oral squamous cell carcinoma. Biochem Biophys Res Commun 2008; 365: 393-8.
19. Maity G, Fahreen S, Banerji A et al. Fibronectin-integrin mediated signaling in human cervical cancer cells (SiHa). Mol Cell Biochem 2010; 336: 65-74.
20. Hofmann UB, Westphal JR, Van Kraats AA, Ruiter DJ, Van Muijen GN. Expression of integrin alpha(v)beta(3) correlates with activation of membranetype matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo. Int J Cancer 2000; 87: 12-9.
21. Sodek KL, Brown TJ, Ringuette MJ. Collagen I but not Matrigel matrices provide an MMP-dependent barrier to ovarian cancer cell penetration. BMC Cancer 2008; 8: 223.
22. Devy L, Huang L, Naa L et al. Selective inhibition ofmatrixmetalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Res 2009; 69: 1517-26.
23. Zhang X, Liu Y, Gilcrease MZ et al. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 2002; 95: 1663-72.
24. Jimi E, Aoki K, Saito H et al. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat Med 2004; 10: 617-24.
25. Tas SW, Vervoordeldonk MJ, Hajji N, May MJ, Ghosh S, Tak PP. Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation. Arthritis Res Ther 2006; 8: R86.
26. Dai S, Hirayama T, Abbas S, Abu-Amer Y. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem 2004; 279: 37219-22.
27. Hayakawa Y, Maeda S, Nakagawa H et al. Effectiveness of IkappaB kinase inhibitors in murine colitis-associated tumorigenesis. J Gastroenterol 2009; 44: 935-43.
28. Shibata W, Maeda S, Hikiba Y et al. Cutting edge: the IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis. J Immunol 2007; 179: 2681-5.
29. Clohisy JC, Yamanaka Y, Faccio R, Abu-Amer Y. Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysis. J Orthop Res 2006; 24: 1358-65.
30. Thomas RP, Farrow BJ, Kim S, May MJ, Hellmich MR, Evers BM. Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death. Surgery 2002; 132: 127-34.
31. Ianaro A, Tersigni M, Belardo G et al. NEMO-binding domain peptide inhibits proliferation of human melanoma cells. Cancer Lett 2009; 274: 331-6.
32. Gaurnier-Hausser A, Patel R, Baldwin AS, May MJ, Mason NJ. NEMObinding domain peptide inhibits constitutive NF-kappaB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma. Clin Cancer Res 2011; 17: 4661-71.
33. Kiessling MK, Klemke CD, Kaminski MM, Galani IE, Krammer PH, Gulow K. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma. Cancer Res 2009; 69: 2365-74.
34. Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 2005; 70: 700-13.
35. Maeda S, Hikiba Y, Sakamoto K et al. Ikappa B kinasebeta/nuclear factorkappaB activation controls the development of liver metastasis by way of interleukin-6 expression. Hepatology 2009; 50: 1851-60.
36. Yan M, Xu Q, Zhang P, Zhou XJ, Zhang ZY, Chen WT. Correlation of NFkappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma. BMC Cancer 2010; 10: 437.
37. Pierce JW, Schoenleber R, Jesmok G et al. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997; 272: 21096-103.
38. Li B, Li YY, Tsao SW, Cheung AL. Targeting NF-kappaB signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer. Mol Cancer Ther 2009; 8: 2635-44.
39. Wysong A, Asher SA, Yin X et al. Selective inhibition of NF-kappa-B inhibition with NBD peptide reduces tumor-induced wasting in a murine model of cancer cachexia in vivo. J Cancer Sci Ther 2011; 3: 22-9.